al-Rodhan N R, Richelson E, Gilbert J A, McCormick D J, Kanba K S, Pfenning M A, Nelson A, Larson E W, Yaksh T L
Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905.
Brain Res. 1991 Aug 23;557(1-2):227-35. doi: 10.1016/0006-8993(91)90139-m.
Neurotensin, an endogenous tridecapeptide, produces a potent, naloxone-insensitive antinociceptive response when it is microinjected into the periaqueductal gray region of the rat brainstem. In the present study, the ED50 for neurotensin in inducing antinociception was 1.5 nmol, two times more potent than morphine. We sought to find whether neurotensin's antinociceptive effects were mediated by the same receptor that mediates its other functions. We found that the structure-activity relationship of neurotensin-induced antinociception was different from that required for the stimulation of intracellular cyclic GMP production in neuroblastoma clone N1E-115 and the binding to N1E-115 cells, human brain tissue, or rat periaqueductal gray. These data suggest there exists a subtype of neurotensin receptors in neural tissue that mediates its antinociceptive actions.
神经降压素是一种内源性十三肽,当微量注射到大鼠脑干导水管周围灰质区域时,会产生一种强效的、对纳洛酮不敏感的抗伤害感受反应。在本研究中,神经降压素诱导抗伤害感受的半数有效剂量(ED50)为1.5纳摩尔,其效力是吗啡的两倍。我们试图探究神经降压素的抗伤害感受作用是否由介导其其他功能的同一受体介导。我们发现,神经降压素诱导抗伤害感受的构效关系不同于在神经母细胞瘤克隆N1E-115中刺激细胞内环鸟苷酸(cGMP)生成以及与N1E-115细胞、人脑组织或大鼠导水管周围灰质结合所需的构效关系。这些数据表明,神经组织中存在一种神经降压素受体亚型,它介导神经降压素的抗伤害感受作用。